This is what ChatGPT has to say about the differences between Sarah Cannon and UPenn:-
The Sarah Cannon Research Institute (SCRI) and University of Pennsylvania (UPenn) are both highly respected in the field of oncology research, but they serve different roles.
UPenn, particularly with its Perelman School of Medicine, is renowned for pioneering CAR-T technology, with foundational work done by Dr. Carl June and his team.
SCRI, however, is distinguished for its clinical trials network, offering access to early-phase clinical trials and a large patient base. While it may not be more "advanced" in technology development than UPenn, its strength lies in clinical trial execution.
The other equally important reason may be to do with IP and our part in developing the technology further. CLTX was also developed in conjunction with Sarah Cannon RI. This from our 2023 Annual Report:-
Ann: University of Pennsylvania joins CHM CDH17 Phase 1/2 trial, page-14
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.5¢ |
Change
0.001(7.14%) |
Mkt cap ! $13.57M | |||
| Open | High | Low | Value | Volume |
| 1.5¢ | 1.5¢ | 1.4¢ | $6.908K | 463.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1888496 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.5¢ | 106056 | 2 |
View Market Depth
| Last trade - 13.12pm 27/09/2024 (20 minute delay) ? |
| CHM (ASX) Chart |